Kymera Therapeutics, Inc. (KYMR)

78.12 -2.23 (-2.78%) USD  |  NASDAQ  |  Dec 30, 16:00
77.90 -0.22 (-0.28%) After-Hours: 20:00
More

Kymera Therapeutics Tobin's Q (Approximate) (Quarterly)

Tobin's Q (Approximate) (Quarterly) Chart

View Tobin's Q (Approximate) (Quarterly) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Tobin's Q (Approximate) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years

View Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Tobin's Q (Approximate) (Quarterly) Benchmarks

View Tobin's Q (Approximate) (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Cytokinetics, Inc. Upgrade
TG Therapeutics, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade